Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12077587 Anti-CD8 antibodies and uses thereof

Patent 12077587 was granted and assigned to Regeneron Pharmaceuticals on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Regeneron Pharmaceuticals

0

Current Assignee

Regeneron Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

William Olson0

Jason T. Giurleo0

Richard Tavare0

Gavin Thurston0

Dangshe Ma0

Date of Patent

September 3, 2024

0

Patent Application Number

180499720

Date Filed

October 26, 2022

0

Patent Citations

US Patent 9546206 High affinity PD-1 agents and methods of use

0

US Patent 7087411 Fusion protein capable of binding VEGF

0

US Patent 8771966 Immuno-PET imaging of antibodies and immunoconjugates and uses therefor

0

US Patent 9429584 Antibody against insoluble fibrin

0

US Patent 9475874 Nucleic acids encoding human antibodies to sialyl-lewis

0

US Patent 10730944 Anti-CD8 antibodies and uses thereof

0

Patent Primary Examiner

Karl J Puttlitz

0

Patent abstract

Anti-CD8 antibodies, radiolabeled anti-CD8 antibodies, fluorescently labeled anti-CD8 antibodies and their use in imaging are provided herein. Included are methods of detecting the presence of CD8 proteins in a subject or sample.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12077587 Anti-CD8 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool